Free access for registered Healthcare Professionals and home of "The Oncology Podcast"
Join us today for the latest oncology news, commentary, educational resources and podcasts
oncologynetwork.com.au
Dive into The Oncology Journal Club 🎧 S3E10: I am large, I contain multitudes!
Expert insights on cancer control measures, the microbiome & surprising research highlights. Thanks to @craigunderhill.bsky.social, Chris Jackson + Kate Clarke #OJC
Listen👉 t.ly/pmcHH
Dive into The Oncology Journal Club 🎧 S3E10: I am large, I contain multitudes!
Expert insights on cancer control measures, the microbiome & surprising research highlights. Thanks to @craigunderhill.bsky.social, Chris Jackson + Kate Clarke #OJC
Listen👉 t.ly/pmcHH
@drkiwikate.bsky.social takes over hosting duties as @craigunderhill.bsky.social covers GU + lung highlights, with a London Global Cancer Week preview from Christopher Jackson
Nuanced analysis, sharp insights + OJC banter! #OncologyPodcast
@drkiwikate.bsky.social takes over hosting duties as @craigunderhill.bsky.social covers GU + lung highlights, with a London Global Cancer Week preview from Christopher Jackson
Nuanced analysis, sharp insights + OJC banter! #OncologyPodcast
You can learn more about the program highlights in our Special Preview podcast here: t.ly/ly9fx #GICancer #GIOncology #CancerResearch #Collaboration #MedEd
You can learn more about the program highlights in our Special Preview podcast here: t.ly/ly9fx #GICancer #GIOncology #CancerResearch #Collaboration #MedEd
It’s ESMO Oncology Journal Club time! Part 1 t.ly/hk8pe
@craigunderhill.bsky.social, @drkiwikate.bsky.social & Christopher Jackson break down the abstracts from #ESMO2025
#OJC #MedEd #OncologyPodcast
It’s ESMO Oncology Journal Club time! Part 1 t.ly/hk8pe
@craigunderhill.bsky.social, @drkiwikate.bsky.social & Christopher Jackson break down the abstracts from #ESMO2025
#OJC #MedEd #OncologyPodcast
Listen here: t.ly/ZKF16 or wherever you get your podcasts| @agitg.bsky.social #GIcancer #CancerResearch #OncologyPodcast #Oncology
Listen here: t.ly/ZKF16 or wherever you get your podcasts| @agitg.bsky.social #GIcancer #CancerResearch #OncologyPodcast #Oncology
🧬 Non-op management of MMR-deficient tumours
📊 Clinical trial design standards
🎯 HER2-negative metastatic breast cancer
And much more! Listen now 👉 t.ly/XvKag
#Oncology #OncologyPodcast #MedEd #OJC #MedSky #OncSky #CanSky @craigunderhill.bsky.social
🧬 Non-op management of MMR-deficient tumours
📊 Clinical trial design standards
🎯 HER2-negative metastatic breast cancer
And much more! Listen now 👉 t.ly/XvKag
#Oncology #OncologyPodcast #MedEd #OJC #MedSky #OncSky #CanSky @craigunderhill.bsky.social
80% response rate in injected tumours in a Phase IIa soft tissue sarcoma trial using the novel drug tigilanol tiglate —a compound sourced from a rainforest plant🌿
🔗 oncologynews.com.au/tumour-strea...
#CancerResearch #RareCancers #CanSky #OncSky #MedSky #Cancer
80% response rate in injected tumours in a Phase IIa soft tissue sarcoma trial using the novel drug tigilanol tiglate —a compound sourced from a rainforest plant🌿
🔗 oncologynews.com.au/tumour-strea...
#CancerResearch #RareCancers #CanSky #OncSky #MedSky #Cancer
Join the OJC team for expert insights, sharp analysis & a dose of humour as they unpack the biggest stories from #ASCO25 #asco2025
👉 Listen: t.ly/h6hT- or via apps
#Oncology #CancerResearch #OJC #MedSky #OncSky #CanSky @craigunderhill.bsky.social
Join the OJC team for expert insights, sharp analysis & a dose of humour as they unpack the biggest stories from #ASCO25 #asco2025
👉 Listen: t.ly/h6hT- or via apps
#Oncology #CancerResearch #OJC #MedSky #OncSky #CanSky @craigunderhill.bsky.social
ASCO 2025 Special – Part 1 is here!
Join @craigunderhill.bsky.social, Dr Kate Clarke and Prof Christopher Jackson they unpack key highlights and hot topics from #ASCO25
Listen now 👉 oncologynews.com.au/events/s3e4-...
#Oncology #CancerResearch #ASCO2025 #OJC
ASCO 2025 Special – Part 1 is here!
Join @craigunderhill.bsky.social, Dr Kate Clarke and Prof Christopher Jackson they unpack key highlights and hot topics from #ASCO25
Listen now 👉 oncologynews.com.au/events/s3e4-...
#Oncology #CancerResearch #ASCO2025 #OJC
Is tissue the issue in #BRCA testing for advanced #ProstateCancer?
Rachael Babin chats to Fiona MacLean & Matthew Roberts to unpack tissue challenges & testing evolution
🎙️ Listen now: oncologynetwork.com.au/brca-testing...
#CanSky #OncSky #MedSky @astra-zeneca.bsky.social
Is tissue the issue in #BRCA testing for advanced #ProstateCancer?
Rachael Babin chats to Fiona MacLean & Matthew Roberts to unpack tissue challenges & testing evolution
🎙️ Listen now: oncologynetwork.com.au/brca-testing...
#CanSky #OncSky #MedSky @astra-zeneca.bsky.social
Why we must rethink care for those living “in the place in between.”
🎙️ Listen: t.ly/6ODFq
#Cancer #SupportiveCare #CanSky #OncSky #MedSky #MedEd
Why we must rethink care for those living “in the place in between.”
🎙️ Listen: t.ly/6ODFq
#Cancer #SupportiveCare #CanSky #OncSky #MedSky #MedEd
Explore how @MonashPCCC is advancing precision oncology + fostering equitable access for patients with #Cancer in #Victoria
Listen now 👉 t.ly/RiPv1 or via Youtube, Apple etc
#PrecisionOncology #Equity #SkyMed #CanMed #OncMed
Explore how @MonashPCCC is advancing precision oncology + fostering equitable access for patients with #Cancer in #Victoria
Listen now 👉 t.ly/RiPv1 or via Youtube, Apple etc
#PrecisionOncology #Equity #SkyMed #CanMed #OncMed
Prof Mark Shackleton joins us to discuss how the MPCCC is transforming cancer care access across Victoria—through molecular tumour boards, fellowships & more.
Don't miss it.
🎙️http://t.ly/dks3m
#Oncology #MPCCC #HealthcareEquity #CanSky #OncSky #MedSky
Listen here for a fresh and fun antipodean perspective: t.ly/be6Xx
Shout out to @eaeisenhauer.bsky.social @drjnaidoo.bsky.social + @ascocancer.bsky.social
#Cansky #Oncsky #Medsky
Listen here for a fresh and fun antipodean perspective: t.ly/be6Xx
Shout out to @eaeisenhauer.bsky.social @drjnaidoo.bsky.social + @ascocancer.bsky.social
#Cansky #Oncsky #Medsky
Join Prof Tim Price + Prof Jeanne Tie for an insightful discussion on BRAFV600E-mutant metastatic colorectal cancer
Listen: t.ly/vtbMy | #Oncology #Cancer #GICancer #GI #ColorectalCancer #BRAFV600E
Join Prof Tim Price + Prof Jeanne Tie for an insightful discussion on BRAFV600E-mutant metastatic colorectal cancer
Listen: t.ly/vtbMy | #Oncology #Cancer #GICancer #GI #ColorectalCancer #BRAFV600E
Explore the National Lung Cancer Screening Program, latest research and implementation strategies
For registration: vcccalliance.org.au/news-and-eve...
#LungCancer #LungCancerScreening #CanSky
@vcccalliance.bsky.social
Explore the National Lung Cancer Screening Program, latest research and implementation strategies
For registration: vcccalliance.org.au/news-and-eve...
#LungCancer #LungCancerScreening #CanSky
@vcccalliance.bsky.social
Join Tim Price & Jeanne Tie for From Consensus to Clinic: Part 2 as they dive into managing BRAFV600E-mutant mCRC
🔬 Imaging & monitoring
🧬 ctDNA & tumour markers
🎯 Local ablative therapies & more!
Listen: t.ly/U7DZs
#GICancer #mCRC #OncSky #OncoSky #MedSky #GISky #CanSky
𝗗𝗘𝗜 in healthcare has been 𝘀𝗵𝗮𝗸𝗲𝗻 𝘁𝗼 𝗶𝘁𝘀 𝗰𝗼𝗿𝗲. 𝗣𝗿𝗼𝗳 𝗖𝗿𝗮𝗶𝗴 𝗨𝗻𝗱𝗲𝗿𝗵𝗶𝗹𝗹, 𝗗𝗿. 𝗞𝗮𝘁𝗲 𝗖𝗹𝗮𝗿𝗸e & 𝗣𝗿𝗼𝗳 𝗖𝗵𝗿𝗶𝘀 𝗝𝗮𝗰𝗸𝘀𝗼𝗻 discuss these radical shifts & what they mean for the future of equitable cancer care.
👉 𝗟𝗶𝘀𝘁𝗲𝗻 𝗻𝗼𝘄 tinyurl.com/4b8hbpc6
@craigunderhill.bsky.social #MedSky
𝗗𝗘𝗜 in healthcare has been 𝘀𝗵𝗮𝗸𝗲𝗻 𝘁𝗼 𝗶𝘁𝘀 𝗰𝗼𝗿𝗲. 𝗣𝗿𝗼𝗳 𝗖𝗿𝗮𝗶𝗴 𝗨𝗻𝗱𝗲𝗿𝗵𝗶𝗹𝗹, 𝗗𝗿. 𝗞𝗮𝘁𝗲 𝗖𝗹𝗮𝗿𝗸e & 𝗣𝗿𝗼𝗳 𝗖𝗵𝗿𝗶𝘀 𝗝𝗮𝗰𝗸𝘀𝗼𝗻 discuss these radical shifts & what they mean for the future of equitable cancer care.
👉 𝗟𝗶𝘀𝘁𝗲𝗻 𝗻𝗼𝘄 tinyurl.com/4b8hbpc6
@craigunderhill.bsky.social #MedSky
Join Profs @Tim Price & @JeanneTie to break down the latest expert consensus on #BRAFV600E-mutant #mCRC in the Asia-Pacific region
🎙️ PART 1: Molecular testing, treatment sequencing & BEACON insights—don’t miss it!
🔗 t.ly/idW9V #medsky #oncsky #cansky #GIsky #cancer
Join Profs @Tim Price & @JeanneTie to break down the latest expert consensus on #BRAFV600E-mutant #mCRC in the Asia-Pacific region
🎙️ PART 1: Molecular testing, treatment sequencing & BEACON insights—don’t miss it!
🔗 t.ly/idW9V #medsky #oncsky #cansky #GIsky #cancer
Dive into the evolving world of HER2-low expression in metastatic breast cancer.
🎙️ Join Prof. Fran Boyle & Dr. Sanjeev Kumar to unpack HER2 testing, patient comms & emerging therapies
🔗 Listen now: t.ly/jFmny #MedSky #OncSky #CanSky #OncologyPodcast #BreastCancer #HER2Low #HER2
Dive into the evolving world of HER2-low expression in metastatic breast cancer.
🎙️ Join Prof. Fran Boyle & Dr. Sanjeev Kumar to unpack HER2 testing, patient comms & emerging therapies
🔗 Listen now: t.ly/jFmny #MedSky #OncSky #CanSky #OncologyPodcast #BreastCancer #HER2Low #HER2
"It makes accruing my professional development points a pleasure and not a chore!"
Listen here: t.ly/tjQ2o
#SupportiveCare #Podcast #MedSky #OncSky #CancerSky
"It makes accruing my professional development points a pleasure and not a chore!"
Listen here: t.ly/tjQ2o
#SupportiveCare #Podcast #MedSky #OncSky #CancerSky